Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Evaluation of the Safety and Tolerability of Rapid Infusion of Biosimilar Rituximab Truxima® — the University College London Hospitals (UCLH) Experience

Raakhee Shah, MPharm, Simon Cheesman, BPharm, Kirit M Ardeshna, MD, Kate Cwynarski, MD, David C. Linch, FRCP, Andres E. Virchis, FRCP, FRCPath, Jonathan Richard Lambert, Christopher Mcnamara, William Townsend

Blood (2017) 130 (Supplement 1): 3387.

https://doi.org/10.1182/blood.V130.Suppl_1.3387.3387

Published: 2017

Journal Articles

Automated Manufacture of CAR19 Donor Lymphocytes Incorporated into an Escalated Dose DLI Protocol: Preliminary Results from the CARD Study

Blood (2017) 130 (Supplement 1): 1993.

https://doi.org/10.1182/blood.V130.Suppl_1.1993.1993

Published: 2017

Journal Articles

Synthetic Lethal Screening Identifies CHK1 Inhibition As an Exploitable Vulnerability in EZH2 Deficient T-ALL

Theresa E. Leon, PhD MSc, BSc, Tanya Rapoz-D'Silva, BSc, MSc, Sunniyat Rahman, MBiochem, DIC, PhD, Michael Magnussen, BSc, MSc, Nadine Farah, MBBChir, MA, MRCP, FRCPath, Jose A. Guerra-Assunção, BSc, PhD, Rajeev Gupta, MB.ChB, PhD FRCP, FRCPath, Elisabeth P. Nacheva, MD PhD, Javier Herrero, PhD, David C. Linch, FRCP, Marc R. Mansour, MD PhD FRCPath

Blood (2017) 130 (Supplement 1): 1325.

https://doi.org/10.1182/blood.V130.Suppl_1.1325.1325

Published: 2017

Journal Articles

Genome-Wide Methylation Analysis of Patients with Diffuse Large B Cell Lymphoma Treated on the UK NCRI R-CHOP 14 Vs 21 Trial

Andrea Kühnl, MD, Ridwan Shaikh, David Cunningham, Sharon L Barrans, Cathy H Burton, Andrew Jack, Mary Gleeson, Nicholas Counsell, Paul Smith, Oliver Schofield, David C. Linch, FRCP, Michael Hubank, PhD

Blood (2016) 128 (22): 1747.

https://doi.org/10.1182/blood.V128.22.1747.1747

Published: 2016

Journal Articles

Treatment Of Non-Hodgkin’s Lymphoma With Secondary Central Nervous System Involvement: Encouraging Response Rates Using CNS-Penetrating Idaram Chemotherapy

Paul M Maciocia, MRCP, Mohsin Badat, MB BChir, Simon Cheesman, Jonathan Lambert, MD, Martin Pule, MD, David C. Linch, FRCP, Kirit M Ardeshna, FRCPath

Blood (2013) 122 (21): 4367.

https://doi.org/10.1182/blood.V122.21.4367.4367

Published: 2013

Journal Articles

The Impact of MN1 Over-Expression on the Outcome of Younger Patients with AML Treated with Intensive Chemotherapy with or without ATRA Therapy

Carol Guy, Amanda Gilkes, Rosemary Gale, PhD, David C. Linch, FRCP, Robert Hills, MA, MSc, DPhil, Alan K. Burnett, MD, FRCP

Blood (2008) 112 (11): 2978.

https://doi.org/10.1182/blood.V112.11.2978.2978

Published: 2008

Journal Articles

Mismatch at 1-2 HLA Loci Does Not Reduce Survival Following Alemtuzumab-Based Reduced Intensity Unrelated Donor Allogeneic Transplantation

Adam J Mead, Kirsty J Thomson, Emma C Morris, Ronjon Chakraverty, David C. Linch, FRCP, Stephen Mackinnon, MD, Karl S Peggs

Blood (2008) 112 (11): 3008.

https://doi.org/10.1182/blood.V112.11.3008.3008

Published: 2008

Journal Articles

The Impact of FLT3-ITD and NPM1 Mutational Status on the Outcome of ATRA Therapy in Patients with Non-APL AML: Results of the UK MRC AML12 Trial

Rosemary Gale, PhD, Robert Hills, MA, MSc, DPhil, Claire Green, Yashma Patel, Amanda Gilkes, Michelle Lazenby, Keith Wheatley, DPhil, David C. Linch, FRCP, Alan Burnett

Blood (2008) 112 (11): 554.

https://doi.org/10.1182/blood.V112.11.554.554

Published: 2008

Journal Articles

FLT3 ITD and TKD Mutations Differ in Their Functional Consequence in Both Cell Line Models and Primary Hematopoietic Cells

Adam J Mead, Asim Khwaja, Rosemary Gale, PhD, David C. Linch, FRCP

Blood (2008) 112 (11): 3791.

https://doi.org/10.1182/blood.V112.11.3791.3791

Published: 2008

Journal Articles

The Relationship Between Wild Type and Mutant-Positive Platelets in Essential Thrombocythemia Patients with a JAK2 V617F Mutation

Jonathan R Lambert, MRCP, Rosemary Gale, PhD, David C. Linch, FRCP

Blood (2008) 112 (11): 3728.

https://doi.org/10.1182/blood.V112.11.3728.3728

Published: 2008

Journal Articles

High Incidence of Notch-1 Mutations in Adult Patients with T-Cell Acute Lymphoblastic Leukaemia.

Marc R. Mansour, MB, ChB, David C. Linch, FRCP, Letizia Foroni, PhD, Anthony H. Goldstone, FRCP, Rosemary E. Gale, PhD

Blood (2005) 106 (11): 1447.

https://doi.org/10.1182/blood.V106.11.1447.1447

Published: 2005

NARROW

Evaluation of the Safety and Tolerability of Rapid Infusion of Biosimilar Rituximab Truxima® — the University College London Hospitals (UCLH) Experience

Automated Manufacture of CAR19 Donor Lymphocytes Incorporated into an Escalated Dose DLI Protocol: Preliminary Results from the CARD Study

Synthetic Lethal Screening Identifies CHK1 Inhibition As an Exploitable Vulnerability in EZH2 Deficient T-ALL

Genome-Wide Methylation Analysis of Patients with Diffuse Large B Cell Lymphoma Treated on the UK NCRI R-CHOP 14 Vs 21 Trial

Treatment Of Non-Hodgkin’s Lymphoma With Secondary Central Nervous System Involvement: Encouraging Response Rates Using CNS-Penetrating Idaram Chemotherapy

The Impact of MN1 Over-Expression on the Outcome of Younger Patients with AML Treated with Intensive Chemotherapy with or without ATRA Therapy

Mismatch at 1-2 HLA Loci Does Not Reduce Survival Following Alemtuzumab-Based Reduced Intensity Unrelated Donor Allogeneic Transplantation

The Impact of FLT3-ITD and NPM1 Mutational Status on the Outcome of ATRA Therapy in Patients with Non-APL AML: Results of the UK MRC AML12 Trial

FLT3 ITD and TKD Mutations Differ in Their Functional Consequence in Both Cell Line Models and Primary Hematopoietic Cells

The Relationship Between Wild Type and Mutant-Positive Platelets in Essential Thrombocythemia Patients with a JAK2 V617F Mutation

High Incidence of Notch-1 Mutations in Adult Patients with T-Cell Acute Lymphoblastic Leukaemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only